Skip to main content
. 2019 Nov 7;71(6):1834–1842.e1. doi: 10.1016/j.jvs.2019.07.102

Table IV.

Postoperative outcomes

CMSG (n = 69) PMSG (n = 28) Overall (N = 97)
30-Day mortality 3 (4) 4 (14) 7 (7)
In-hospital mortality 3 (4) 4 (14) 7 (7)
Cause of death
 Myocardial infarction 0 (0) 1 (3.5) 1 (1)
 Stroke 0 (0) 1 (3.5) 1 (1)
 Bowel or colonic ischemia 2 (3) 1 (3.5) 3 (3)
 Pulmonary infection 0 (0) 1 (3.5) 1 (1)
 Access infection 1 (1) 0 (0) 1 (1)
Patients presenting with ≥1 nonfatal complication 15 (22) 7 (25) 22 (23)
Total of nonfatal postoperative complications 16 8 24
 Stroke 1 (1) 0 (0) 1 (1)
 Spinal cord ischemia 3 (4) 2 (7) 5 (5)
 Definitive 1 (1) 0 (0) 1 (1)
 Partially regressive 0 (0) 1 (3.5) 1 (1)
 Totally regressive 2 (3) 1 (3.5) 3 (3)
 Renal failure requiring hemodialysis 1 (1) 0 (0) 1 (1)
 Bowel or colonic ischemia 3 (4) 0 (0) 3 (3)
 Severe acute respiratory syndrome 2 (3) 0 (0) 2 (2)
 Transient renal failure 4 (6) 4 (14) 8 (8)
 Hemorrhage 1 (1) 2 (7) 3 (3)
 Access site infection 1 (1) 0 (0) 1 (1)

CMSG, Custom-made stent graft; PMSG, physician-modified stent graft.

Values are reported as number (%).